An Efficacy and Safety Study With Integrated Pharmacokinetics (PK) and Pharmacodynamic (PD) Assessment to Compare the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis (RMS)

RECRUITING

Sandoz Investigational Site, Ormond Beach

RECRUITING

Sandoz Investigational Site, Maitland

RECRUITING

Sandoz Investigational Site, Banja Luka

RECRUITING

Sandoz Investigational Site, Sarajevo

RECRUITING

Sandoz Investigational Site, Pleven

RECRUITING

Sandoz Investigational Site, Plovdiv

RECRUITING

Sandoz Investigational Site, Sofia

RECRUITING

Sandoz Investigational Site, Varaždin

RECRUITING

Sandoz Investigational Site, Zagreb

RECRUITING

Sandoz Investigational Site, Rustavi

RECRUITING

Sandoz Investigational Site, Tbilisi

RECRUITING

Sandoz Investigational Site, Shtip

RECRUITING

Sandoz Investigational Site, Skopje

RECRUITING

Sandoz Investigational Site, Bydgoszcz

RECRUITING

Sandoz Investigational Site, Katowice

RECRUITING

Sandoz Investigational Site, Lodz

RECRUITING

Sandoz Investigational Site, Nowa Sól

RECRUITING

Sandoz Investigational Site, Poznan

RECRUITING

Sandoz Investigational Site, Warsaw

RECRUITING

Sandoz Investigational Site, Zabrze

RECRUITING

Sandoz Investigational Site, Belgrade

RECRUITING

Sandoz Investigational Site, Niš